Process View
The expansion of a B cell population by cell division. Follows B cell activation.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "b cell proliferation"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.862 | ||
| PTPN6 | protein tyrosine phosphatase, non-receptor type 6 | 0.834 | ||
| IL4R | interleukin 4 receptor | 0.666 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.423 | ||
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.404 | ||
| SYK | spleen tyrosine kinase | 0.361 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.356 | ||
| BCL2L11 | BCL2-like 11 (apoptosis facilitator) | 0.332 | ||
| IL10RA | interleukin 10 receptor, alpha | 0.234 | ||
| ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.222 | Mouse | |
| CD80 | CD80 molecule | 0.221 | ||
| LCP2 | lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) | 0.179 | ||
| MS4A1 | membrane-spanning 4-domains, subfamily A, member 1 | 0.154 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.131 | ||
| TAL1 | T-cell acute lymphocytic leukemia 1 | 0.123 | ||
| CASP9 | caspase 9, apoptosis-related cysteine peptidase | 0.106 | ||
| INPP5D | inositol polyphosphate-5-phosphatase, 145kDa | 0.098 | Mouse | |
| CD22 | CD22 molecule | 0.096 | ||
| CD79B | CD79b molecule, immunoglobulin-associated beta | 0.095 | ||
| BCL2 | B-cell CLL/lymphoma 2 | 0.094 | ||
| TICAM2 | toll-like receptor adaptor molecule 2 | 0.092 | ||
| LAT | linker for activation of T cells | 0.089 | ||
| BCL2L1 | BCL2-like 1 | 0.082 | Human | |
| IL2RG | interleukin 2 receptor, gamma | 0.080 | ||
| MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 0.080 | Human | |
| MYD88 | myeloid differentiation primary response gene (88) | 0.080 | ||
| SLAMF1 | signaling lymphocytic activation molecule family member 1 | 0.077 | ||
| APAF1 | apoptotic peptidase activating factor 1 | 0.069 | ||
| BLNK | B-cell linker | 0.069 | ||
| SH3BP2 | SH3-domain binding protein 2 | 0.066 | ||
| LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 0.063 | ||
| IL22RA2 | interleukin 22 receptor, alpha 2 | 0.062 | ||
| EP300 | E1A binding protein p300 | 0.054 | ||
| XIAP | X-linked inhibitor of apoptosis | 0.054 | ||
| HLA-DPA1 | major histocompatibility complex, class II, DP alpha 1 | 0.051 | ||
| CCR7 | chemokine (C-C motif) receptor 7 | 0.049 | ||
| CD86 | CD86 molecule | 0.047 | ||
| GRAP2 | GRB2-related adaptor protein 2 | 0.046 | ||
| CDK6 | cyclin-dependent kinase 6 | 0.045 | ||
| CDK2 | cyclin-dependent kinase 2 | 0.044 | ||
| BIRC3 | baculoviral IAP repeat containing 3 | 0.043 | ||
| TFF1 | trefoil factor 1 | 0.043 | ||
| PECAM1 | platelet/endothelial cell adhesion molecule | 0.042 | ||
| HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 0.041 | ||
| CCND1 | cyclin D1 | 0.040 | ||
| VAV1 | vav 1 guanine nucleotide exchange factor | 0.039 | Human | |
| PTK2B | PTK2B protein tyrosine kinase 2 beta | 0.038 | ||
| INSR | insulin receptor | 0.038 | ||
| LCK | lymphocyte-specific protein tyrosine kinase | 0.037 | ||
| CXCR4 | chemokine (C-X-C motif) receptor 4 | 0.037 | ||
| ID3 | inhibitor of DNA binding 3, dominant negative helix-loop-helix protein | 0.034 | ||
| FCGR2B | Fc fragment of IgG, low affinity IIb, receptor (CD32) | 0.034 | Mouse | |
| STAT6 | signal transducer and activator of transcription 6, interleukin-4 induced | 0.033 | ||
| GRB7 | growth factor receptor-bound protein 7 | 0.033 | ||
| CD19 | CD19 molecule | 0.031 | ||
| MUC1 | mucin 1, cell surface associated | 0.031 | ||
| TCF4 | transcription factor 4 | 0.030 | Human | |
| HDAC9 | histone deacetylase 9 | 0.030 | ||
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.029 | Mouse | |
| GAS7 | growth arrest-specific 7 | 0.028 | ||
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.027 | ||
| CDCP1 | CUB domain containing protein 1 | 0.027 | ||
| TP53 | tumor protein p53 | 0.027 | ||
| SH2D1A | SH2 domain containing 1A | 0.027 | ||
| ARNT | aryl hydrocarbon receptor nuclear translocator | 0.026 | ||
| PRKCB | protein kinase C, beta | 0.025 | ||
| RB1 | retinoblastoma 1 | 0.025 | ||
| ITGAL | integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) | 0.025 | ||
| UHRF2 | ubiquitin-like with PHD and ring finger domains 2 | 0.024 | ||
| HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 | 0.024 | ||
| PPP1CC | protein phosphatase 1, catalytic subunit, gamma isozyme | 0.024 | ||
| USP7 | ubiquitin specific peptidase 7 (herpes virus-associated) | 0.024 | ||
| PIAS4 | protein inhibitor of activated STAT, 4 | 0.023 | ||
| ABI2 | abl-interactor 2 | 0.023 | ||
| MSH5 | mutS homolog 5 (E. coli) | 0.022 | ||
| CCND3 | cyclin D3 | 0.022 | ||
| CYSLTR1 | cysteinyl leukotriene receptor 1 | 0.022 | Human | |
| LY96 | lymphocyte antigen 96 | 0.022 | ||
| LAIR1 | leukocyte-associated immunoglobulin-like receptor 1 | 0.021 | ||
| IRF4 | interferon regulatory factor 4 | 0.021 | ||
| IL22RA1 | interleukin 22 receptor, alpha 1 | 0.020 | ||
| BAK1 | BCL2-antagonist/killer 1 | 0.020 | ||
| WASF1 | WAS protein family, member 1 | 0.019 | ||
| CDKN2C | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) | 0.019 | ||
| ID2 | inhibitor of DNA binding 2, dominant negative helix-loop-helix protein | 0.019 | ||
| GRB10 | growth factor receptor-bound protein 10 | 0.018 | ||
| PILRA | paired immunoglobin-like type 2 receptor alpha | 0.018 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.018 | ||
| NCOA7 | nuclear receptor coactivator 7 | 0.018 | ||
| TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.018 | ||
| RAPGEF1 | Rap guanine nucleotide exchange factor (GEF) 1 | 0.018 | ||
| HDAC4 | histone deacetylase 4 | 0.018 | ||
| RNF144B | ring finger protein 144B | 0.017 | ||
| GAB2 | GRB2-associated binding protein 2 | 0.017 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.017 | ||
| DDX17 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 17 | 0.017 | ||
| IRS1 | insulin receptor substrate 1 | 0.017 | ||
| MAPK12 | mitogen-activated protein kinase 12 | 0.017 | ||
| FGR | Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog | 0.016 | ||
| FERMT2 | fermitin family member 2 | 0.016 | ||
| CSK | c-src tyrosine kinase | 0.016 | ||
| SIGLEC7 | sialic acid binding Ig-like lectin 7 | 0.016 | ||
| SPI1 | spleen focus forming virus (SFFV) proviral integration oncogene spi1 | 0.015 | ||
| FOXP3 | forkhead box P3 | 0.015 | ||
| EGR1 | early growth response 1 | 0.015 | ||
| NR4A2 | nuclear receptor subfamily 4, group A, member 2 | 0.015 | ||
| CD33 | CD33 molecule | 0.015 | ||
| CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.015 | ||
| TRAF3 | TNF receptor-associated factor 3 | 0.015 | ||
| IRAK4 | interleukin-1 receptor-associated kinase 4 | 0.015 | ||
| HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 and major histocompatibility complex, class II, DR beta 1 | 0.015 | ||
| TRAT1 | T cell receptor associated transmembrane adaptor 1 | 0.015 | ||
| CD72 | CD72 molecule | 0.015 | ||
| TRIM33 | tripartite motif containing 33 | 0.015 | ||
| BID | BH3 interacting domain death agonist | 0.015 | ||
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.015 | ||
| KLF6 | Kruppel-like factor 6 | 0.015 | ||
| IL2RA | interleukin 2 receptor, alpha | 0.014 | ||
| CYSLTR2 | cysteinyl leukotriene receptor 2 | 0.014 | Human | |
| TNFRSF1B | tumor necrosis factor receptor superfamily, member 1B | 0.014 | ||
| FAIM3 | Fas apoptotic inhibitory molecule 3 | 0.014 | ||
| SMC1A | structural maintenance of chromosomes 1A | 0.014 | ||
| HDAC1 | histone deacetylase 1 | 0.014 | ||
| SEMA4D | sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D | 0.014 | ||
| ID1 | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | 0.014 | ||
| UBASH3B | ubiquitin associated and SH3 domain containing B | 0.014 | ||
| RHOH | ras homolog gene family, member H | 0.014 | ||
| TCF12 | transcription factor 12 | 0.014 | Human | |
| HCK | hemopoietic cell kinase | 0.013 | ||
| ITK | IL2-inducible T-cell kinase | 0.013 | ||
| HLA-DQB1 | major histocompatibility complex, class II, DQ beta 1 | 0.013 | ||
| CD6 | CD6 molecule | 0.013 | ||
| SLA | Src-like-adaptor | 0.013 | ||
| APP | amyloid beta (A4) precursor protein | 0.013 | ||
| CXCR5 | chemokine (C-X-C motif) receptor 5 | 0.013 | ||
| CDK4 | cyclin-dependent kinase 4 | 0.013 | ||
| RUNX1 | runt-related transcription factor 1 | 0.013 | ||
| SPRR2D | small proline-rich protein 2D | 0.013 | ||
| CD27 | CD27 molecule | 0.013 | ||
| SIN3A | SIN3 homolog A, transcription regulator (yeast) | 0.013 | ||
| ZNF282 | zinc finger protein 282 | 0.013 | ||
| CD84 | CD84 molecule | 0.013 | ||
| CSF3R | colony stimulating factor 3 receptor (granulocyte) | 0.013 | ||
| JAK1 | Janus kinase 1 | 0.013 | ||
| CD37 | CD37 molecule | 0.012 | ||
| PIK3CG | phosphoinositide-3-kinase, catalytic, gamma polypeptide | 0.012 | ||
| NME1 | non-metastatic cells 1, protein (NM23A) expressed in | 0.012 | ||
| GFER | growth factor, augmenter of liver regeneration | 0.012 | ||
| TRAF5 | TNF receptor-associated factor 5 | 0.012 | ||
| CSF2RB | colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) | 0.012 | ||
| IGSF6 | immunoglobulin superfamily, member 6 | 0.012 | ||
| JAK3 | Janus kinase 3 | 0.012 | ||
| FYB | FYN binding protein | 0.012 | ||
| NCF4 | neutrophil cytosolic factor 4, 40kDa | 0.012 | ||
| TRAF3IP3 | TRAF3 interacting protein 3 | 0.012 | ||
| TXK | TXK tyrosine kinase | 0.012 | ||
| FANCD2 | Fanconi anemia, complementation group D2 | 0.012 | ||
| DYRK1A | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A | 0.012 | ||
| CCNDBP1 | cyclin D-type binding-protein 1 | 0.012 | ||
| IKZF3 | IKAROS family zinc finger 3 (Aiolos) | 0.012 | Mouse | |
| GPR65 | G protein-coupled receptor 65 | 0.011 | ||
| TNFSF8 | tumor necrosis factor (ligand) superfamily, member 8 | 0.011 | ||
| HDAC5 | histone deacetylase 5 | 0.011 | ||
| BAD | BCL2-associated agonist of cell death | 0.011 | ||
| EVI2A | ecotropic viral integration site 2A | 0.011 | ||
| ITGB2 | integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) | 0.011 | ||
| PPAP2B | phosphatidic acid phosphatase type 2B | 0.011 | ||
| TRAF1 | TNF receptor-associated factor 1 | 0.011 | ||
| BCL2A1 | BCL2-related protein A1 | 0.011 | ||
| TCF7L2 | transcription factor 7-like 2 (T-cell specific, HMG-box) | 0.011 | ||
| PTPN22 | protein tyrosine phosphatase, non-receptor type 22 (lymphoid) | 0.011 | ||
| IFNG | interferon, gamma | 0.011 | ||
| IKZF1 | IKAROS family zinc finger 1 (Ikaros) | 0.011 | ||
| IRAK1 | interleukin-1 receptor-associated kinase 1 | 0.011 | ||
| FOSB | FBJ murine osteosarcoma viral oncogene homolog B | 0.011 | ||
| IRF8 | interferon regulatory factor 8 | 0.011 | ||
| ARHGAP25 | Rho GTPase activating protein 25 | 0.011 | ||
| CNR2 | cannabinoid receptor 2 (macrophage) | 0.010 | ||
| AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 0.010 | ||
| IL2RB | interleukin 2 receptor, beta | 0.010 | ||
| SH2D1B | SH2 domain containing 1B | 0.010 | ||
| RNR2 | l-rRNA | 0.010 | ||
| DOK1 | docking protein 1, 62kDa (downstream of tyrosine kinase 1) | 0.010 | ||
| CD28 | CD28 molecule | 0.010 | Human | |
| CR1 | complement component (3b/4b) receptor 1 (Knops blood group) | 0.010 | Human | |
| CTLA4 | cytotoxic T-lymphocyte-associated protein 4 | 0.010 | ||
| P2RY10 | purinergic receptor P2Y, G-protein coupled, 10 | 0.010 | Human | |
| ETS1 | v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) | 0.010 | ||
| PIM1 | pim-1 oncogene | 0.010 | ||
| GLIS2 | GLIS family zinc finger 2 | 0.010 | ||
| CD180 | CD180 molecule | 0.010 | ||
| CD69 | CD69 molecule | 0.010 | ||
| CDKN1B | cyclin-dependent kinase inhibitor 1B (p27, Kip1) | 0.010 | ||
| ENPP1 | ectonucleotide pyrophosphatase/phosphodiesterase 1 | 0.010 | ||
| SPIB | Spi-B transcription factor (Spi-1/PU.1 related) | 0.010 |